Cantor Fitzgerald Comments on Stratasys FY2026 Earnings

Stratasys Ltd. (NASDAQ:SSYS - Free Report) - Research analysts at Cantor Fitzgerald issued their FY2026 earnings estimates for Stratasys in a research report issued to clients and investors on Monday, June 9th. Cantor Fitzgerald analyst T. Jensen anticipates that the technology company will post earnings per share of $0.02 for the year. Cantor Fitzgerald has a "Overweight" rating and a $15.00 price objective on the stock. The consensus estimate for Stratasys' current full-year earnings is ($0.40) per share.

Several other equities analysts also recently issued reports on the stock. Wall Street Zen raised shares of Stratasys from a "hold" rating to a "buy" rating in a research note on Thursday, May 15th. Needham & Company LLC lifted their target price on shares of Stratasys from $12.00 to $13.00 and gave the stock a "buy" rating in a research note on Thursday, March 6th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $12.20.

Stratasys Stock Down 0.1%

Shares of SSYS stock traded down $0.01 during trading hours on Tuesday, hitting $10.65. 332,772 shares of the company's stock traded hands, compared to its average volume of 570,712. The stock's 50 day simple moving average is $9.95 and its 200 day simple moving average is $10.02. The stock has a market cap of $763.78 million, a PE ratio of -8.07 and a beta of 1.52. Stratasys has a 12 month low of $6.05 and a 12 month high of $12.88.

Stratasys (NASDAQ:SSYS - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The technology company reported $0.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.01. The firm had revenue of $136.05 million during the quarter, compared to the consensus estimate of $134.11 million. Stratasys had a negative net margin of 16.13% and a negative return on equity of 3.75%. The company's revenue for the quarter was down 5.6% on a year-over-year basis. During the same quarter last year, the firm earned ($0.02) earnings per share.

Hedge Funds Weigh In On Stratasys

Hedge funds have recently bought and sold shares of the company. Northern Trust Corp raised its stake in Stratasys by 26.0% during the fourth quarter. Northern Trust Corp now owns 44,466 shares of the technology company's stock worth $395,000 after buying an additional 9,168 shares during the last quarter. BNP Paribas Financial Markets grew its holdings in Stratasys by 46.6% in the fourth quarter. BNP Paribas Financial Markets now owns 190,135 shares of the technology company's stock worth $1,690,000 after purchasing an additional 60,407 shares during the period. Hsbc Holdings PLC grew its holdings in Stratasys by 10.4% in the fourth quarter. Hsbc Holdings PLC now owns 16,664 shares of the technology company's stock worth $148,000 after purchasing an additional 1,564 shares during the period. RPG Investment Advisory LLC grew its holdings in Stratasys by 64.6% in the fourth quarter. RPG Investment Advisory LLC now owns 1,086,337 shares of the technology company's stock worth $9,658,000 after purchasing an additional 426,341 shares during the period. Finally, Millennium Management LLC grew its holdings in Stratasys by 8.4% in the fourth quarter. Millennium Management LLC now owns 90,715 shares of the technology company's stock worth $806,000 after purchasing an additional 7,066 shares during the period. Institutional investors own 75.77% of the company's stock.

About Stratasys

Stratasys Ltd. provides connected polymer-based 3D printing solutions. It offers range of 3D printing systems, which includes polyjet printer, Fused Deposition Modeling (FDM) printers, stereolithography printing systems, origin P3 printers, and selective absorption fusion printer for additive manufacturing, and tooling and rapid prototyping for various vertical markets, such as automotive, aerospace, consumer products and healthcare.